NSCLC (Issue 6) | Special Reports

Prior Cancer Diagnosis Not Viable Exclusion From Lung Cancer Trials

February 26, 2015

Clinical Articles

Only about 5% of patients with cancer are recruited into oncology clinical trials, raising a concern that unless this improves, progress in the development new treatments for cancer may be delayed.

Lung Cancer Screening: Implementing the New Protocol

February 25, 2015

Clinical Articles

Early detection in lung cancer is strongly linked to better survival. In a landmark decision the CMS recently approved national coverage for lung cancer screening with LDCT for high-risk smokers.

Liquid Biopsy Use in NSCLC Clinical Practice on the Horizon

February 25, 2015

Clinical Articles

The definition of liquid biopsy has expanded to include the collection of cfDNA, along with various species of cell-free RNA and exosomes, all of which are capable of providing information on the disease status of cancer patients.

Challenges Oncologists Face in Treating Lung Cancer

February 24, 2015

Clinical Articles

Roman Perez-Soler, MD, chairman and chief, department of medical oncology, Montefiore Medical Center, deputy director, Albert Einstein Cancer Center, discusses the challenges oncologists still face in lung cancer.

Potential Modulator of NSCLC Metastasis Identified

February 23, 2015

Clinical Articles

Blocking activin-A, a protein that is secreted by non-small cell lung cancer (NSCLC) cells, may prevent cancer metastasis, according to research conducted at the University of Virginia (UVA).